Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Colombia
100%
Propofol
59%
Healthcare Workers
46%
Cali-Colombia
45%
Epidemiology
41%
COVID-19
39%
Antimicrobial Resistance
39%
Third Level
39%
Anesthesiology
39%
Colombian Patients
39%
N-803
39%
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
39%
Inappropriate Antibiotic Use
33%
Mexico
30%
Latin America (LATAM)
29%
Sexually Transmitted Infections
29%
Antibiotic Use
26%
Operating Room
24%
Healthcare-associated Infections
24%
Antimicrobial
23%
Risk Factors
23%
IL-15 Superagonist
23%
Colombian
23%
Infection Prevention
23%
Papules
23%
Skin Lesions
23%
Natural Killer Cells
23%
Surgical Mask
22%
People Living with HIV (PLHIV)
21%
Bloodstream Infection
21%
Antibiotic Therapy
21%
Mask Wearing
19%
Meta-analysis
19%
Antimicrobial Use
19%
Strongyloides Stercoralis
19%
Hyperinfection Syndrome
19%
Histoid Leprosy
19%
Diphyllobothriosis
19%
Propofol Anesthesia
19%
Tau Protein
19%
Latin American Countries
19%
Unusual Case
19%
Healthcare Impact
19%
Tungiasis
19%
Network Groups
19%
Retroauricular
19%
Hospital Setting
19%
Burn Patients
19%
Bacterial Contamination
19%
Sporadic Creutzfeldt-Jakob Disease (sCJD)
19%
Medicine and Dentistry
Human Immunodeficiency Virus
76%
COVID-19
59%
Severe Acute Respiratory Syndrome Coronavirus 2
39%
Papule
39%
Meta-Analysis
39%
Sexually Transmitted Disease
39%
Public Health
36%
Skin Defect
33%
Prevalence
32%
Immunocompromised Patient
29%
Infection
27%
Healthcare Associated Infection
24%
Operating Room
24%
Malignant Neoplasm
23%
Human Immunodeficiency Virus Infection
21%
Cohort Effect
21%
Bloodstream Infection
21%
Antibiotic Therapy
21%
Anesthesiology
19%
Natural Killer Cell
19%
Antiretroviral Therapy
19%
Propofol
19%
Strongyloides stercoralis
19%
Neuraxial Anesthesia
19%
Symptomatology
19%
Thermal Burn
19%
Reinfection
19%
Meningitis
19%
Subclinical Infection
19%
Urinary Tract Infection
19%
Weil's Disease
19%
Tungiasis
19%
Urine Culture
19%
Cystoscopy
19%
Strongyloides
19%
Halo
19%
Parasitic Disease
19%
Darier's Disease
19%
Intestinal Parasite
19%
Rebound
19%
Carbapenemase Producing Enterobacteriaceae
19%
Seroprevalence
19%
Bacterium Contamination
19%
Bed Bug
19%
Microscopy
19%
Prospective Study
19%
Infection Prevention
19%
Infection Control
19%
Interleukin 2
19%
Outpatient
16%
Immunology and Microbiology
Infectious Disease
82%
Infection
82%
Human Immunodeficiency Virus
76%
Natural Killer Cell
39%
COVID-19
39%
Severe Acute Respiratory Syndrome Coronavirus 2
39%
Interleukin 15
26%
Human Immunodeficiency Virus Infection
23%
Antimicrobial Agent
21%
Ribonucleic Acid
19%
Intestine Parasite
19%
Acinetobacter Baumannii
19%
Dysbiosis
19%
Acinetobacter
19%
Interleukin 2
19%
Lymph Node
19%
Carbapenemase Producing Enterobacteriaceae
19%
Immunocompromised Patient
19%
Rhodnius Prolixus
19%
Multi-Omics
19%
Antimicrobial Stewardship
19%
Triatominae
19%
Seroprevalence
19%
Leptospira
19%
Systemic Inflammation
19%
Acquired Immune Deficiency Syndrome
19%
Antibiotic Resistance
19%
Genetic Variability
19%
Cell Function
13%
Multilocus Sequence Typing
13%
Cohort Effect
12%
Reduviidae
9%
Trypanosoma Cruzi
9%
Experimental Mouse
9%
Blood Plasma
9%
Light Microscopy
9%
Chagas Disease
9%
Hemiptera
9%
Protozoa
9%
Anatomical Concepts
9%
Scanning Electron Microscopy
9%
Epidemiology
8%
Dose Response
7%
Parasite
7%
Prevalence
7%
T Cell
6%
Lineages
6%
Interleukin 6
6%
Molecular Typing
6%
CD4 CD8 Ratio
6%